Comparison of Perforated 3D Printed Versus Conventional Metal Fixed Bonded Retainer
Launched by MARIAM ALAA · Feb 24, 2025
Trial Information
Current as of July 27, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying two types of fixed retainers used to keep teeth in place after orthodontic treatment: a traditional metal retainer and a new 3D printed metal retainer. The goal is to compare how well these two types of retainers hold up over time, especially regarding any failures in their bond to the teeth. Researchers want to find out if one type is better than the other, as there are mixed opinions about how often traditional metal retainers fail.
To participate in this trial, you should have recently completed orthodontic treatment and have a healthy set of teeth, including four permanent lower front teeth and two lower canine teeth. You should also have good oral hygiene and not have any current dental issues, like cavities or gum disease. If you join the study, you can expect to have regular check-ups to monitor how well your assigned retainer is working. This trial is currently looking for participants of all genders between the ages of 18 and 78.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients with properly finished orthodontic treatment.
- • No sex predilection.
- • The presence of 4 permanent mandibular incisors and 2 permanent mandibular canines.
- • No active caries, restorations, fractures, or periodontal disease of previously mentioned teeth
- • Patients with good oral hygiene.
- Exclusion Criteria:
- • Patients with no need of fixed mandibular retention.
- • Enamel hypoplasia or hypocalcification of mandibular anterior teeth.
- • Abnormal morphology of mandibular anterior teeth
- • Periodontal disease that contraindicates fixed orthodontic retention.
- • No or poor patient's compliance \& bad oral hygiene.
- • Psychological problems.
About Mariam Alaa
Mariam Alaa is a dedicated clinical trial sponsor committed to advancing medical research and improving patient outcomes through innovative study designs and rigorous methodologies. With a strong focus on ethical standards and regulatory compliance, Mariam Alaa collaborates with leading research institutions and healthcare professionals to facilitate the development of groundbreaking therapies. By fostering a culture of scientific excellence and transparency, the organization aims to contribute significantly to the understanding and treatment of various medical conditions, ensuring that new therapies are both safe and effective for diverse patient populations.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Giza, , Egypt
Patients applied
Trial Officials
Mariam MA Elsebaey, Phd
Principal Investigator
Cairo University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported